Table 2.
Mental health, infectious diseases, and biomedical HIV prevention.
| Measure | Methamphetamine users | No Drug Use For Sex (NDUS) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mdn= median | IQR IQR= interquartile range | N | Mdn= median | IQR IQR= interquartile range | Mann–Whitney U | p-value | Effect size (r) | |
| PHQ-9 | 117 | 5.00 | 5.00 | 150 | 3.00 | 4.25 | 6,824.0 | .002** | 0.2 |
| GAD-7 | 112 | 3.00 | 4.00 | 149 | 2.00 | 5.00 | 7,398.0 | .113 | 0.1 |
| PHQ-15 | 116 | 4.00 | 5.00 | 151 | 3.00 | 4.00 | 7,595.0 | .061 | 0.1 |
| Traumatic Events Lifetime | 110 | 2.00 | 2.00 | 142 | 1.00 | 2.00 | 6,852.0 | .087 | 0.1 |
| N | % | N | % | Chi2 | p-value | Effect size (Cramer V) | |||
| PTSD screening positive | 110 | 6.4 | 139 | 12.9 | 2.949 | .086 | 0.1 | ||
| PHQ-9 > 10 | 117 | 11.1 | 150 | 12.0 | .051 | .822 | 0.01 | ||
| GAD-7 > 10 | 112 | 5.4 | 149 | 8.7 | 1.074 | .300 | 0.064 | ||
| PHQ-15 > 10 | 116 | 12.9 | 151 | 10.6 | .345 | .555 | 0.036 | ||
| HIV positive | 91 | 52.7 | 96 | 7.2 | 30.670 | .000** | 0.418 | ||
| Hepatitis C infection | 93 | 3.2 | 70 | 0 | 2.300 | .129 | 0.119 | ||
| Condomless anal intercourse | 100 | 93 | 139 | 49.6 | 50.070 | .000** | 0.458 | ||
| PrEP | 43 | 53.8 | 83 | 7.2 | 29.126 | .000** | 0.481 | ||
PHQ-9, Patient Health Questionnaire (PHQ-D) subscale for depressive symptoms; GAD-7, PHQ-D subscale for generalized anxiety symptoms; PHQ-15, (PHQ-D) subscale for somatization symptoms; PTSD, posttraumatic stress disorder; PrEP, pre-exposure prophylaxis. Mdn, median; IQR, interquartile range. **p < .01.